A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia

Autor: Francis, Sebastian, Lucas, Claire, Lane, Steven, Wang, Lihui, Watmough, Sarah, Knight, Katy, Bell, Jo, Kaleel-Rahman, Mohammed, Lee, Edwin, O’Brien, David, Butt, Nauman M., Sadik, Walid, De Soysa, Lally, Seale, Jim R.C., Salim, Rahuman, Clark, Richard E.
Zdroj: In Leukemia Research July 2013 37(7):752-758
Databáze: ScienceDirect
Externí odkaz: